These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 21206378)

  • 41. Long-term effects of an intensive intervention in HIV-infected patients with moderate-high atherosclerotic cardiovascular risk.
    Masiá M; Bernal E; Robledano C; Padilla S; López N; Martínez E; Gutiérrez F
    J Antimicrob Chemother; 2014 Nov; 69(11):3051-6. PubMed ID: 25038306
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of nutritional counseling on low-density lipoprotein cholesterol among Thai HIV-infected adults receiving antiretroviral therapy.
    Chotivichien S; Arab L; Prasithsirikul W; Manosuthi W; Sinawat S; Detels R
    AIDS Care; 2016; 28(2):257-65. PubMed ID: 26295176
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of antiretroviral therapy on serum lipoprotein levels and dyslipidemias: a systematic review and meta-analysis.
    Nduka C; Sarki A; Uthman O; Stranges S
    Int J Cardiol; 2015 Nov; 199():307-18. PubMed ID: 26241636
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of C-reactive protein as a marker for cardiovascular risk associated with antiretroviral therapy in HIV-infected patients.
    Masiá M; Bernal E; Padilla S; Graells ML; Jarrín I; Almenar MV; Molina J; Hernández I; Gutiérrez F
    Atherosclerosis; 2007 Nov; 195(1):167-71. PubMed ID: 17049532
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High Prevalence of Dyslipidemia and Insulin Resistance in HIV-infected Prepubertal African Children on Antiretroviral Therapy.
    Innes S; Abdullah KL; Haubrich R; Cotton MF; Browne SH
    Pediatr Infect Dis J; 2016 Jan; 35(1):e1-7. PubMed ID: 26421804
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of chocolate and mate tea on the lipid profile of individuals with HIV/AIDS on antiretroviral therapy: A clinical trial.
    Souza SJ; Petrilli AA; Teixeira AM; Pontilho PM; Carioca AA; Luzia LA; Souza JM; Damasceno NR; Segurado AA; Rondó PH
    Nutrition; 2017; 43-44():61-68. PubMed ID: 28935146
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The individual and combined influence of HIV and hepatitis C virus on dyslipidaemia in a high-risk Hispanic population.
    Forrester JE; McGovern BH; Rhee MS; Sterling RK
    HIV Med; 2009 Oct; 10(9):555-63. PubMed ID: 19496835
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association of Dyslipidemia and Glucose Abnormalities With Antiretroviral Treatment in a Cohort of HIV-Infected Latin American Children.
    Paganella MP; Cohen RA; Harris DR; de Souza Kuchenbecker R; Sperhacke RD; Kato SK; Oliveira da Silva CL; Sturzbecher FT; Oliveira RH; Pavía-Ruz N; Hazra R;
    J Acquir Immune Defic Syndr; 2017 Jan; 74(1):e1-e8. PubMed ID: 27570910
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Lipid alterations and cardiovascular risk associated with antiretroviral therapy].
    Masiá-Canuto M; Bernal-Morell E; Gutiérrez-Rodero F
    Enferm Infecc Microbiol Clin; 2006 Dec; 24(10):637-48. PubMed ID: 17194390
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk factors for cardiovascular disease in children infected with human immunodeficiency virus-1.
    Miller TL; Orav EJ; Lipshultz SE; Arheart KL; Duggan C; Weinberg GA; Bechard L; Furuta L; Nicchitta J; Gorbach SL; Shevitz A
    J Pediatr; 2008 Oct; 153(4):491-7. PubMed ID: 18538789
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of common familial dyslipidemias in early childhood.
    Lapinleimu J; Lapinleimu H; Nuotio IO; Rönnemaa T; Simell OG; Viikari JS;
    Atherosclerosis; 2009 Jun; 204(2):573-9. PubMed ID: 19026413
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HAART-associated dyslipidemia varies by biogeographical ancestry in the multicenter AIDS cohort study.
    Nicholaou MJ; Martinson JJ; Abraham AG; Brown TT; Hussain SK; Wolinsky SM; Kingsley LA
    AIDS Res Hum Retroviruses; 2013 Jun; 29(6):871-9. PubMed ID: 23343448
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antiretroviral drugs in HIV-infected children.
    Viganò A; Manfredini V; Penagini F; Giacomet V; Zuccotti GV
    Pharmacol Res; 2011 Jul; 64(1):1-3. PubMed ID: 21255650
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Population Pharmacokinetic/Pharmacodynamic Model Predicts Favorable HDL Cholesterol Changes Over the First 5 Years in Children Treated With Current Efavirenz-Based Regimens.
    Homkham N; Cressey TR; Ingsrisawang L; Bouazza N; Ngampiyaskul C; Hongsiriwon S; Srirojana S; Kanjanavanit S; Bhakeecheep S; Coeur SL; Salvadori N; Treluyer JM; Jourdain G; Urien S
    J Clin Pharmacol; 2016 Sep; 56(9):1076-83. PubMed ID: 26749102
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antiretroviral treatment-induced dyslipidemia in HIV-infected patients is influenced by the APOC3-related rs10892151 polymorphism.
    Aragonès G; Alonso-Villaverde C; Pardo-Reche P; Rull A; Beltrán-Debón R; Rodríguez-Gallego E; Fernández-Sender L; Camps J; Joven J
    BMC Med Genet; 2011 Sep; 12():120. PubMed ID: 21939545
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Dietary intake and dyslipidemia arising from combination antiretroviral therapy for HIV infection: a systematic review].
    Almeida LB; Giudici KV; Jaime PC
    Arq Bras Endocrinol Metabol; 2009 Jul; 53(5):519-27. PubMed ID: 19768243
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Blood lactate in HIV-infected children on antiretroviral therapy in rural South Africa.
    van Ramshorst MS; Struthers HE; McIntyre JA; Peters RP
    Pediatr Infect Dis J; 2014 Apr; 33(4):393-5. PubMed ID: 23995586
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evidence from the field: missed opportunities for identifying and linking HIV-infected children for early initiation of ART.
    Chamla D; Mbori-Ngacha D; Newman M; Kellerman SE; Sugandhi N; Rwebembera A; Elyanu P; Murungu J; Kiyaga C; Luo C; McClure C;
    AIDS; 2013 Nov; 27 Suppl 2():S139-46. PubMed ID: 24361623
    [No Abstract]   [Full Text] [Related]  

  • 59. Impact of pharmaceutical care on cardiovascular risk among older HIV patients on antiretroviral therapy.
    Domingues EA; Ferrit-Martín M; Calleja-Hernández MÁ
    Int J Clin Pharm; 2017 Feb; 39(1):52-60. PubMed ID: 27864732
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Triad of the Ischemic Cardiovascular Disease in People Living with HIV? Association Between Risk Factors, HIV Infection, and Use of Antiretroviral Therapy.
    Zanetti HR; Mendes EL; Palandri Chagas AC; Gomes Douglas MO; Paranhos Lopes LT; Roever L; Gonçalves A; Santos Resende E
    Curr Atheroscler Rep; 2018 May; 20(6):30. PubMed ID: 29777448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.